SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $4.00 | Prev. Close $3.83 | Circuit Range N/A |
Day Range $4.00 - $4.00 | Year Range $0.22 - $4.87 | Volume 154 |
Average Traded $4.00 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
27-Apr-26 | $3.96 | $3.81 | -12.41% |
24-Apr-26 | $4.35 | $4.35 | -1.81% |
22-Apr-26 | $4.32 | $4.43 | +2.67% |
21-Apr-26 | $4.62 | $4.32 | -6.80% |
20-Apr-26 | $4.06 | $4.63 | +8.81% |
17-Apr-26 | $4.22 | $4.25 | +1.92% |
16-Apr-26 | $3.85 | $4.17 | +7.46% |